DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Papadakis KA, Shayne OA, Vasiliauskas EA. et al.
Safety and efficacy of adalimumab (D2E7) in Crohn’s disease patients with an attenuated response to Infliximab.
Am J Gastroenterol 2005; 100: 75-79
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.